Last reviewed · How we verify
Cycles N8, N5 and N6 — Competitive Intelligence Brief
phase 3
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Cycles N8, N5 and N6 (Cycles N8, N5 and N6) — University of Cologne. Cycles N8, N5 and N6 are likely involved in the regulation of cell cycle progression.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cycles N8, N5 and N6 TARGET | Cycles N8, N5 and N6 | University of Cologne | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cycles N8, N5 and N6 CI watch — RSS
- Cycles N8, N5 and N6 CI watch — Atom
- Cycles N8, N5 and N6 CI watch — JSON
- Cycles N8, N5 and N6 alone — RSS
Cite this brief
Drug Landscape (2026). Cycles N8, N5 and N6 — Competitive Intelligence Brief. https://druglandscape.com/ci/cycles-n8-n5-and-n6. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab